Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q2 FY24 results · Jul–Sep 2023
Divi's Laboratories reported revenue from operations of ₹1,909.00 crore (up 2.9% from Q2 FY23) and net profit of ₹348.00 crore (down 29.5% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,909.00 | 1,854.54 | +2.9% | 1,778.00 | +7.4% |
| Other income | 86.00 | 80.08 | +7.4% | 81.00 | +6.2% |
| Total income | 1,995.00 | 1,934.62 | +3.1% | 1,859.00 | +7.3% |
| Profit before tax | 469.00 | 615.22 | −23.8% | 492.00 | −4.7% |
| Net profit for the period | 348.00 | 493.60 | −29.5% | 356.00 | −2.2% |
| EPS, basic (₹) | 13.11 | 18.60 | −29.5% | 13.41 | −2.2% |
| Net margin (%) | 18.2 | 26.6 | 20.0 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,868.00 | 1,823.38 | +2.4% | 1,730.00 | +8.0% |
| Other income | 85.00 | 79.25 | +7.3% | 80.00 | +6.2% |
| Total income | 1,953.00 | 1,902.63 | +2.6% | 1,810.00 | +7.9% |
| Profit before tax | 464.00 | 602.90 | −23.0% | 478.00 | −2.9% |
| Net profit for the period | 342.00 | 486.85 | −29.8% | 345.00 | −0.9% |
| EPS, basic (₹) | 12.89 | 18.34 | −29.7% | 12.99 | −0.8% |
| Net margin (%) | 18.3 | 26.7 | 19.9 |
Consolidated
- Filed with BSE
- 07 Nov 2023, 12:56 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2023, 12:56 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE